XML 39 R20.htm IDEA: XBRL DOCUMENT v3.25.0.1
BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION
 
We have four reportable business segments (Asia, Europe, North America and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. Each of the geographic segments operate under the Nature’s Sunshine Products and Synergy WorldWide brands and sell similar products grouped into six principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities, independent of the Company, that we have granted distribution rights for the relevant market.

The Company's chief operating decision maker ("CODM") is our president and chief executive officer. The CODM assesses the performance of each segment using operating income. The CODM reviews the performance of each segment using monthly internal reports which provide variance analysis of actual results by segment compared to budget, forecast and prior year. The CODM uses this information when making decisions about the allocation of operating resources to each segment. The CODM does not evaluate reportable segments using asset or liability information.
Reportable business segment information for the years ended December 31, 2024 and 2023 is as follows (dollar amounts in thousands):
2024AsiaEuropeNorth AmericaLatin America and OtherTotal
Net sales$207,794 $84,837 $138,849 $22,884 $454,364 
Cost of sales48,557 27,836 45,364 7,918 
Volume incentives69,685 33,758 29,773 7,374 
Selling, general and administrative (1)55,443 18,577 32,793 6,299 
Segment operating income$34,109 $4,666 $30,919 $1,293 $70,987 
Unallocated corporate selling, general and administrative expense(50,892)
Operating income20,095 
Interest and other income, net177 
Interest expense(146)
Foreign exchange losses, net(1,700)
Income from operations before provision for income taxes$18,426 

2023AsiaEuropeNorth AmericaLatin America and OtherTotal
Net sales$201,251 $81,101 $139,804 $23,164 $445,320 
Cost of sales45,373 25,397 45,347 8,076 
Volume incentives65,143 33,486 29,392 7,299 
Selling, general and administrative (1)60,185 18,434 30,655 6,288 
Segment operating income$30,550 $3,784 $34,410 $1,501 $70,245 
Unallocated corporate selling, general and administrative expense(51,496)
Operating income18,749 
Interest and other income, net552 
Interest expense(69)
Foreign exchange gains, net970 
Income from operations before provision for income taxes$20,202 
___________________________
(1) Service fees in China totaled $14.5 million and $16.6 million for the years ended December 31, 2024 and 2023, respectively. These service fees are included in our selling, general and administrative expenses for our Asia segment.

The table below reflects sales based upon the sales location where they occurred. From an individual country/region perspective, only the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the years ended December 31, 2024 and 2023 as follows (dollar amounts in thousands):
Year Ended December 31,20242023
Net sales:  
United States$127,924 $129,305 
Taiwan70,579 61,691 
South Korea51,362 49,845 
Other204,499 204,479 
Total net sales$454,364 $445,320 
Net sales generated by each product line for the years ended December 31, 2024 and 2023 are as follows (dollar amounts in thousands):
2024AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$81,313$36,631$59,520$6,418$183,882
Immunity12,0528,45415,8022,41638,724
Cardiovascular56,2669,26514,4431,72681,700
Digestive38,95822,74839,32510,713111,744
Personal care5,0325,3976,2411,13317,803
Weight management14,1732,3423,51847820,511
Total net sales by segment$207,794$84,837$138,849$22,884$454,364

2023AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$69,037 $34,709 $63,742 $6,286 $173,774 
Immunity5,4208,22216,1242,70332,469
Cardiovascular57,7719,14314,9591,71883,591
Digestive36,43422,11134,62810,693103,866
Personal care5,5864,9776,4761,26218,301
Weight management27,0031,9393,87550233,319
Total net sales by segment$201,251 $81,101 $139,804 $23,164 $445,320 

Year Ended December 31,20242023
Depreciation and amortization:  
Asia$1,876 $1,812 
Europe93 54 
North America12,204 9,890 
Latin America and Other46 60 
Total depreciation and amortization$14,219 $11,816 

From an individual country perspective, only the United States has material balances of consolidated property, plant and equipment as follows (dollar amounts in thousands):
As of December 31 20242023
Property, plant and equipment, net  
United States$34,786 $41,239 
Other4,799 3,761 
Total property, plant and equipment$39,585 $45,000